Cancer survivorship: an integral part of Europe's research agenda
Cancer survivorship has traditionally received little prioritisation and attention. For a long time, the treatment of cancer has been the main focus of healthcare providers’ efforts. It is time to increase the amount of attention given to patients’ long‐term well‐being and their ability to return to...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-03-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.12428 |
| _version_ | 1819203696586653696 |
|---|---|
| author | Pernilla Lagergren Anna Schandl Neil K. Aaronson Hans‐Olov Adami Francesco deLorenzo Louis Denis Sara Faithfull Lifang Liu Franḉoise Meunier Cornelia Ulrich the European Academy of Cancer Sciences |
| author_facet | Pernilla Lagergren Anna Schandl Neil K. Aaronson Hans‐Olov Adami Francesco deLorenzo Louis Denis Sara Faithfull Lifang Liu Franḉoise Meunier Cornelia Ulrich the European Academy of Cancer Sciences |
| author_sort | Pernilla Lagergren |
| collection | DOAJ |
| description | Cancer survivorship has traditionally received little prioritisation and attention. For a long time, the treatment of cancer has been the main focus of healthcare providers’ efforts. It is time to increase the amount of attention given to patients’ long‐term well‐being and their ability to return to a productive and good life. This article describes the current state of knowledge and identifies research areas in need of development to enable interventions for improved survivorship for all cancer patients in Europe. The article is summed up with 11 points in need of further focus. |
| first_indexed | 2024-12-23T04:24:01Z |
| format | Article |
| id | doaj.art-c701bea111c64729b2371b3d4507d379 |
| institution | Directory Open Access Journal |
| issn | 1574-7891 1878-0261 |
| language | English |
| last_indexed | 2024-12-23T04:24:01Z |
| publishDate | 2019-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Molecular Oncology |
| spelling | doaj.art-c701bea111c64729b2371b3d4507d3792022-12-21T18:00:10ZengWileyMolecular Oncology1574-78911878-02612019-03-0113362463510.1002/1878-0261.12428Cancer survivorship: an integral part of Europe's research agendaPernilla Lagergren0Anna Schandl1Neil K. Aaronson2Hans‐Olov Adami3Francesco deLorenzo4Louis Denis5Sara Faithfull6Lifang Liu7Franḉoise Meunier8Cornelia Ulrich9the European Academy of Cancer SciencesSurgical Care Science Department of Molecular medicine and Surgery Karolinska Institutet Karolinska University Hospital Stockholm SwedenSurgical Care Science Department of Molecular medicine and Surgery Karolinska Institutet Karolinska University Hospital Stockholm SwedenDivision of Psychosocial Research & Epidemiology The Netherlands Cancer Institute Amsterdam The NetherlandsDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm SwedenEuropean Cancer Patient Coalition Brussels BelgiumOncology Centre Antwerp BelgiumFaculty of Health and Medical Sciences University of Surrey Guildford UKFédération of European Academies of Medicine Brussels BelgiumFédération of European Academies of Medicine Brussels BelgiumHuntsman Cancer Institute Salt Lake City UT USACancer survivorship has traditionally received little prioritisation and attention. For a long time, the treatment of cancer has been the main focus of healthcare providers’ efforts. It is time to increase the amount of attention given to patients’ long‐term well‐being and their ability to return to a productive and good life. This article describes the current state of knowledge and identifies research areas in need of development to enable interventions for improved survivorship for all cancer patients in Europe. The article is summed up with 11 points in need of further focus.https://doi.org/10.1002/1878-0261.12428cancer researchcomprehensive cancer centreslong‐term effectsresearch programmessurvivors |
| spellingShingle | Pernilla Lagergren Anna Schandl Neil K. Aaronson Hans‐Olov Adami Francesco deLorenzo Louis Denis Sara Faithfull Lifang Liu Franḉoise Meunier Cornelia Ulrich the European Academy of Cancer Sciences Cancer survivorship: an integral part of Europe's research agenda Molecular Oncology cancer research comprehensive cancer centres long‐term effects research programmes survivors |
| title | Cancer survivorship: an integral part of Europe's research agenda |
| title_full | Cancer survivorship: an integral part of Europe's research agenda |
| title_fullStr | Cancer survivorship: an integral part of Europe's research agenda |
| title_full_unstemmed | Cancer survivorship: an integral part of Europe's research agenda |
| title_short | Cancer survivorship: an integral part of Europe's research agenda |
| title_sort | cancer survivorship an integral part of europe s research agenda |
| topic | cancer research comprehensive cancer centres long‐term effects research programmes survivors |
| url | https://doi.org/10.1002/1878-0261.12428 |
| work_keys_str_mv | AT pernillalagergren cancersurvivorshipanintegralpartofeuropesresearchagenda AT annaschandl cancersurvivorshipanintegralpartofeuropesresearchagenda AT neilkaaronson cancersurvivorshipanintegralpartofeuropesresearchagenda AT hansolovadami cancersurvivorshipanintegralpartofeuropesresearchagenda AT francescodelorenzo cancersurvivorshipanintegralpartofeuropesresearchagenda AT louisdenis cancersurvivorshipanintegralpartofeuropesresearchagenda AT sarafaithfull cancersurvivorshipanintegralpartofeuropesresearchagenda AT lifangliu cancersurvivorshipanintegralpartofeuropesresearchagenda AT francoisemeunier cancersurvivorshipanintegralpartofeuropesresearchagenda AT corneliaulrich cancersurvivorshipanintegralpartofeuropesresearchagenda AT theeuropeanacademyofcancersciences cancersurvivorshipanintegralpartofeuropesresearchagenda |